PARP
PARP Inhibitors
Read More about this categoryShow Less
Poly (ADP-ribose) polymerases (PARPs) is a large family of proteins with a conserved catalytic domain that catalyze an immediate DNA-damage-dependent post-translational modification of histones and other nuclear proteins leading to the survival of injured proliferating cells. So far, a total number of 18 human PARP proteins encoded by different genes have been identified, including PARP-1 to PARP-4, PARP-5a, PARP-5b, PARP-5c and PARP-6 to PARP-16. The general structural of PARP proteins has been revealed through the extensive study of the founding family member PARP-1, which is characterized by the presence of four functional domains, including a DNA-binding domain, a caspase-cleaved domain, an automodification domain and a catalytic domain.
Products Related to PARP(162)
- GC73633TNKS-2-IN-2CAS: 2719726-91-5Purity: >99.00%
TNKS-2-IN-2 ist ein potenter und selektiver TNKS2-Inhibitor mit einem IC50 von 22 nM.
- GC73639PARP7-IN-16CAS: 2435657-10-4Purity: >95.00%
PARP7-IN-16 (Verbindung 36) ist ein potenter, selektiver und oral aktiver Inhibitor von PARP-1/2/7, mit IC50s von 0.94, 0.87 und 0.21 nM, jeweils.
- GC73640PARP7-IN-16 free baseCAS: 2136325-05-6
PARP7-IN-16 free base ist die freie Basisform von PARP7-IN-16.
- GC73919AZD-9574-acidCAS: 2923687-90-3
AZD-9574-acid (70D), ein PPAR-1 Inhibitor, kann für die Synthese von PROTAC (CAS 2923686-70-6) verwendet werden.
- GC73943Polθ/PARP-IN-1Purity: >99.00%
Polθ/PARP-IN-1 (Verbindung 25d) ist ein potenter dualer DNA-Polymerase-Theta (Polθ) und PARP-Inhibitor mit IC50-Werten von 45,6, 5,4 nM.
- GC74078PARP1-IN-29CAS: 1567375-93-2
PARP1-IN-29 ist ein oral aktiver PARP-1-Inhibitor mit einem IC50-Wert von 6,3 nM.
- GC78810Anisomelic acidCAS: 59632-76-7Purity: >98.00%
Anisomelic acid is a human papillomavirus HPV16 E6 and HPV E7 depletor.
- GC78957(2S,3R,4S)-ASX-173CAS: 2748800-07-7Purity: >99.00%
(2S,3R,4S)-ASX-173 is the (2S,3R,4S)-enantiomer of ASX-173.
- GC79058PARP1/NAMPT-IN-1CAS: 3084810-86-3Purity: >98.00%
PARP1/NAMPT-IN-1 is a potent and dual PARP1 and NAMPT inhibitor with IC 50 values of 1.2 nM and 6.7 nM, respectively.
- GC79061PARP1-IN-56CAS: 1574367-80-8Purity: >99.00%
PARP1-IN-56 (Compound RCY) is an I-labeled poly(ADP−ribose) polymerase ( PARP1 ) inhibitor.
- GC79577PFKFB4-IN-1CAS: 2664831-55-2Purity: >99.50%
PFKFB4-IN-1 is a potent and selective ATP-competitive PFKFB4 inhibitor ( IC 50 = 4.50 μM) that reduces intracellular PFKFB4 protein levels.
- GC79871CHNQD-00824CAS: 2222643-74-3Purity: >98.00%
CHNQD-00824 is a Terphenyllin derivative with potent anticancer effect.
- GC80334Rucaparib-d 3CAS: 2271225-13-7Purity: >98.00%
Rucaparib -d 3 (AG014699-d 3 ) is the deuterated -labeled Rucaparib.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC73633 | TNKS-2-IN-2 | 2719726-91-5 | >99.00% | |
TNKS-2-IN-2 ist ein potenter und selektiver TNKS2-Inhibitor mit einem IC50 von 22 nM. | ||||
| GC73639 | PARP7-IN-16 | 2435657-10-4 | >95.00% | |
PARP7-IN-16 (Verbindung 36) ist ein potenter, selektiver und oral aktiver Inhibitor von PARP-1/2/7, mit IC50s von 0.94, 0.87 und 0.21 nM, jeweils. | ||||
| GC73640 | PARP7-IN-16 free base | 2136325-05-6 | - | |
PARP7-IN-16 free base ist die freie Basisform von PARP7-IN-16. | ||||
| GC73642 | ALK-IN-26 | 2447607-85-2 | >99.00% | |
ALK-IN-26 ist ein ALK-Inhibitor mit einem IC50-Wert von 7,0 μM für ALK-Tyrosinkinase. | ||||
| GC73760 | Trilexium | 1983180-82-0 | >99.00% | |
Trilexium (TRX-E-009-1) ist eine dritte Generation von Benzopyran, die strukturell mit TRX-E-002-1 verwandt ist. | ||||
| GC73919 | AZD-9574-acid | 2923687-90-3 | - | |
AZD-9574-acid (70D), ein PPAR-1 Inhibitor, kann für die Synthese von PROTAC (CAS 2923686-70-6) verwendet werden. | ||||
| GC73943 | Polθ/PARP-IN-1 | - | >99.00% | |
Polθ/PARP-IN-1 (Verbindung 25d) ist ein potenter dualer DNA-Polymerase-Theta (Polθ) und PARP-Inhibitor mit IC50-Werten von 45,6, 5,4 nM. | ||||
| GC74078 | PARP1-IN-29 | 1567375-93-2 | - | |
PARP1-IN-29 ist ein oral aktiver PARP-1-Inhibitor mit einem IC50-Wert von 6,3 nM. | ||||
| GC78810 | Anisomelic acid | 59632-76-7 | >98.00% | |
Anisomelic acid is a human papillomavirus HPV16 E6 and HPV E7 depletor. | ||||
| GC78957 | (2S,3R,4S)-ASX-173 | 2748800-07-7 | >99.00% | |
(2S,3R,4S)-ASX-173 is the (2S,3R,4S)-enantiomer of ASX-173. | ||||
| GC78958 | TMLB-C16 | 2923531-50-2 | >99.00% | |
TMLB-C16 is a potent and orally active B3GAT3 inhibitor with a K D of 3.962 μM. | ||||
| GC78961 | GPS167 | 3034312-19-8 | >98.00% | |
GPS167 is a CLK kinase inhibitor that potently and selectively inhibits recombinant human CLK1, CLK2 and CLK4. | ||||
| GC79050 | OUL312 | - | >99.00% | |
OUL312 is a potent PARP10 inhibitor ( IC 50 = 20 nM), showing more than 75-fold greater selectivity for PARP15 ( IC 50 = 1500 nM). | ||||
| GC79056 | KMR-206 | 2992741-10-1 | >99.50% | |
KMR-206 is a PARP7 inhibitor with an IC 50 of 13.7 nM. | ||||
| GC79058 | PARP1/NAMPT-IN-1 | 3084810-86-3 | >98.00% | |
PARP1/NAMPT-IN-1 is a potent and dual PARP1 and NAMPT inhibitor with IC 50 values of 1.2 nM and 6.7 nM, respectively. | ||||
| GC79060 | A-620223 | 272769-49-0 | >96.00% | |
A-620223 is a PARP-1 inhibitor with a K i of 8 nM against PARP-1 and EC 50 of 3 nM in a whole cell assay. | ||||
| GC79061 | PARP1-IN-56 | 1574367-80-8 | >99.00% | |
PARP1-IN-56 (Compound RCY) is an I-labeled poly(ADP−ribose) polymerase ( PARP1 ) inhibitor. | ||||
| GC79062 | PCIP-1 | - | >98.50% | |
PCIP-1 is a PARP2 inhibitor. | ||||
| GC79063 | TNKS-IN-1 | 59455-93-5 | >99.50% | |
TNKS-IN-1 is a selective and potent tankyrase ( TNKS1 / TNKS2 ) inhibitor with IC 50 values of 7.9 nM and 8.7 nM. | ||||
| GC79072 | MS6076 | - | >98.00% | |
MS6076 is a mitochondrial protease ClpP agonist. | ||||
| GC79451 | JP-11646 | 1902983-63-4 | >98.50% | |
JP-11646 is a pan-PIM inhibitor with increased potency against PIM2 ( IC 50 = 0.5 nM). | ||||
| GC79577 | PFKFB4-IN-1 | 2664831-55-2 | >99.50% | |
PFKFB4-IN-1 is a potent and selective ATP-competitive PFKFB4 inhibitor ( IC 50 = 4.50 μM) that reduces intracellular PFKFB4 protein levels. | ||||
| GC79871 | CHNQD-00824 | 2222643-74-3 | >98.00% | |
CHNQD-00824 is a Terphenyllin derivative with potent anticancer effect. | ||||
| GC80334 | Rucaparib-d 3 | 2271225-13-7 | >98.00% | |
Rucaparib -d 3 (AG014699-d 3 ) is the deuterated -labeled Rucaparib. | ||||
